There is substantial epidemiological evidence linking hyperphosphataemia and cardiovascular and all-cause mortality among patients with ESRD, especially above 6 mg/dl (1.9 mmol/l)
There is substantial epidemiological evidence linkinghyperphosphataemia and cardiovascular and all-causemortality among patients with ESRD, especially above6 mg/dl (1.9 mmol/l)